mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
0.096 |
0.004 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.004 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.004 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.004 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.005 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.005 |